Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.
<h4>Background</h4>Hepatocellular carcinoma (HCC) is characterized by late detection and fast progression, and it is believed that epigenetic disruption may be the cause of its molecular and clinicopathological heterogeneity. A better understanding of the global deregulation of methylati...
Guardado en:
Autores principales: | Hector Hernandez-Vargas, Marie-Pierre Lambert, Florence Le Calvez-Kelm, Géraldine Gouysse, Sandrine McKay-Chopin, Sean V Tavtigian, Jean-Yves Scoazec, Zdenko Herceg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/389baa5725c54169a07b5d9e17960c62 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DNA methylation characteristics of primary melanomas with distinct biological behaviour.
por: Szilvia Ecsedi, et al.
Publicado: (2014) -
Joint-specific DNA methylation and transcriptome signatures in rheumatoid arthritis identify distinct pathogenic processes
por: Rizi Ai, et al.
Publicado: (2016) -
Yeast Plasma Membrane Fungal Oligopeptide Transporters Display Distinct Substrate Preferences despite Their High Sequence Identity
por: Carmen Becerra-Rodríguez, et al.
Publicado: (2021) -
Integrative genomics identifies gene signature associated with melanoma ulceration.
por: Zsuzsa Rakosy, et al.
Publicado: (2013) -
Mast Cells Resting-Related Prognostic Signature in Hepatocellular Carcinoma
por: Hao Zhang, et al.
Publicado: (2021)